Insider Transactions in Q4 2023 at Sab Biotherapeutics, Inc. (SABS)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 07
2023
|
Eddie Joe Sullivan PRESIDENT |
BUY
Open market or private purchase
|
Direct |
1,740
+0.03%
|
$0
$0.88 P/Share
|
|
Nov 30
2023
|
Michael King CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$0
$0.9 P/Share
|
|
Nov 29
2023
|
Samuel J Reich CEO & EXECUTIVE CHAIRMAN |
BUY
Open market or private purchase
|
Direct |
11,000
+4.78%
|
$0
$0.89 P/Share
|
|
Nov 24
2023
|
Helen K. Ellias |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,857,142
+50.0%
|
-
|
|
Nov 24
2023
|
Andrew Moin |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,584,571
+50.0%
|
-
|
|
Nov 24
2023
|
Sessa Capital (Master), L.P. Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,584,571
+50.0%
|
-
|